Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jailendra Singh
TRU
Jailendra Singh
Wall Street Analyst
★★★★☆
#542
on 13Foresight · ranked by our own returns
63%
Success Rate
+6.0%
Average Return
31 of 49 calls profitable · +1.9% vs benchmark
📈 Across the calls we could measure, roughly 63% of Jailendra Singh's ratings turned a profit when each position was held for 1 year — averaging +6.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

124 Buy 97 Hold 0 Sell
Jailendra's Stock Coverage 48 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
PHR
Phreesia
Jun 12, 2026 HOLD Strong Buy
+82.2% avg upside
21 analysts
·
EVH
Evolent Health
Jun 12, 2026 BUY Strong Buy
+121.1% avg upside
19 analysts
$7.00
55.82% Upside
·
HNGE
Hinge Health, Inc. Class A
Jun 11, 2026 BUY Strong Buy
+7.5% avg upside
17 analysts
$85.00
22.53% Upside
+0.9%
HIMS
Hims & Hers Health
Jun 09, 2026 HOLD Buy
-27.8% avg upside
22 analysts
·
AMWL
American Well
Jun 08, 2026 HOLD Hold
+64.5% avg upside
15 analysts
$7.50
11.01% Downside
·
PRVA
Privia Health Group
Jun 08, 2026 BUY Strong Buy
+34.1% avg upside
26 analysts
$33.00
39.43% Upside
·
VEEV
Veeva Systems
Jun 04, 2026 BUY Buy
+54.2% avg upside
36 analysts
$262.00
70.84% Upside
-9.2%
ARDT
Ardent Health Partners, Inc.
Jun 03, 2026 BUY Buy
+52.6% avg upside
16 analysts
+16.0%
ASTH
Astrana Health
Jun 01, 2026 BUY Strong Buy
+37.0% avg upside
16 analysts
+1.1%
TDOC
Teladoc
Jun 01, 2026 HOLD Buy
+257.8% avg upside
37 analysts
$9.00
11.47% Upside
-10.4%
ICLR
Icon
May 28, 2026 HOLD Strong Buy
+24.0% avg upside
25 analysts
+8.0%
IQV
IQVIA Holdings
May 26, 2026 BUY Strong Buy
+34.3% avg upside
38 analysts
+10.1%
DOCS
Doximity
May 18, 2026 HOLD Buy
+61.4% avg upside
27 analysts
$19.00
7.10% Downside
+5.6%
AGL
Agilon Health
May 18, 2026 HOLD Buy
-59.1% avg upside
26 analysts
$67.00
41.06% Downside
+31.1%
GDRX
GoodRx Holdings
May 15, 2026 HOLD Buy
+387.3% avg upside
28 analysts
+7.4%
PGNY
Progyny
May 11, 2026 BUY Strong Buy
+11.9% avg upside
14 analysts
$30.00
14.98% Upside
+14.9%
BTMD
biote
May 07, 2026 BUY Strong Buy
+109.5% avg upside
8 analysts
-5.7%
MDLN
Medline
May 07, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$56.00
55.86% Upside
-14.1%
FTRE
Fortrea Holdings Inc.
May 06, 2026 BUY Buy
-3.5% avg upside
11 analysts
$19.00
24.04% Upside
-14.2%
WAY
Waystar Holding Corp.
Apr 30, 2026 BUY Strong Buy
+106.0% avg upside
29 analysts
-13.9%
MEDP
Medpace Holdings
Apr 24, 2026 HOLD Buy
-12.0% avg upside
16 analysts
$462.00
0.45% Upside
+13.8%
RVMD
Revolution Medicines
Feb 27, 2026 BUY Strong Buy
-12.2% avg upside
32 analysts
$116.00
28.73% Downside
+54.6%
CRMD
Cormedix
Sep 04, 2025 BUY Strong Buy
+73.5% avg upside
13 analysts
-33.3%
TSE:BHC
Bausch Health Companies
Jul 30, 2025 HOLD Buy
+783.6% avg upside
29 analysts
·
SMMT
Summit Therapeutics
Jul 17, 2025 BUY Strong Buy
+112.6% avg upside
27 analysts
-49.8%
CNC
Centene
Jul 02, 2025 BUY Buy
+8.7% avg upside
28 analysts
+79.5%
CI
Cigna
May 05, 2025 BUY Strong Buy
+23.8% avg upside
29 analysts
-15.5%
ELV
Elevance Health
Apr 21, 2025 BUY Strong Buy
+10.8% avg upside
32 analysts
-17.6%
SRRK
Scholar Rock Holding
Jan 13, 2025 BUY Strong Buy
+20.2% avg upside
23 analysts
+2.7%
CHRS
Coherus Biosciences
Nov 19, 2024 BUY Buy
+748.3% avg upside
18 analysts
+41.1%
HUM
Humana
Oct 03, 2024 HOLD Buy
-11.2% avg upside
34 analysts
+19.0%
AVAH
Aveanna Healthcare Holdings
Sep 09, 2024 HOLD Buy
+16.7% avg upside
17 analysts
+50.7%
CRBU
Caribou Biosciences
Sep 04, 2024 BUY Strong Buy
+581.8% avg upside
12 analysts
-2.6%
LLY
Eli Lilly & Co
Jul 03, 2024 BUY Strong Buy
-10.5% avg upside
47 analysts
-12.5%
HCA
HCA Healthcare
Apr 29, 2024 BUY Buy
+14.2% avg upside
35 analysts
+10.2%
PNTG
Pennant Group
Apr 16, 2024 HOLD Strong Buy
+5.8% avg upside
9 analysts
$22.00
34.19% Downside
+30.9%
UNH
UnitedHealth
Nov 29, 2022 BUY Strong Buy
+2.4% avg upside
35 analysts
$610.00
52.13% Upside
+2.8%
GOCOQ
GoHealth
Aug 16, 2022 HOLD Hold
+3352.4% avg upside
11 analysts
$18.75
5257.11% Upside
·
EHTH
Ehealth
Mar 03, 2022 HOLD Hold
+869.6% avg upside
19 analysts
$16.00
869.72% Upside
-21.8%
ACH
Accendra Health
Feb 28, 2022 HOLD Hold
+439.4% avg upside
17 analysts
$43.00
1231.27% Upside
-65.3%
DH
Definitive Healthcare Corp
Feb 24, 2022 HOLD Hold
+658.6% avg upside
19 analysts
$24.00
3057.86% Upside
-45.1%
SLQT
SelectQuote
Feb 08, 2022 HOLD Buy
+685.4% avg upside
16 analysts
$4.00
304.70% Upside
-56.1%
CAH
Cardinal Health
Jan 07, 2022 HOLD Strong Buy
-12.8% avg upside
29 analysts
$62.00
72.00% Downside
+49.6%
CLOV
Clover Health Investments
Jan 07, 2022 SELL Hold
-29.4% avg upside
9 analysts
$3.50
29.93% Downside
+68.0%
MCK
McKesson
Jan 07, 2022 BUY Strong Buy
-2.2% avg upside
27 analysts
$333.00
55.56% Downside
+55.5%
COR
Cencora
Jan 07, 2022 BUY Buy
+14.6% avg upside
43 analysts
$180.00
33.80% Downside
+26.0%
OSCR
Oscar Health
Nov 11, 2021 BUY Buy
-34.1% avg upside
15 analysts
$21.00
25.97% Downside
-76.3%
PI
IMPINJ
Feb 26, 2020 BUY Strong Buy
+12.4% avg upside
16 analysts
$30.00
76.68% Downside
+103.8%
🔒 43 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Jailendra Singh — Frequently Asked Questions
How accurate are Jailendra Singh's stock ratings?
Based on the calls 13Foresight could measure, about 63% of Jailendra's ratings were profitable over a one-year hold, with an average return of +6.0% per rating, or +2.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Jailendra ranked on 13Foresight?
Jailendra Singh is currently ranked #542 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jailendra cover?
Jailendra most recently has ratings on PHR, EVH, HNGE, HIMS, AMWL, PRVA, VEEV, ARDT, ASTH, TDOC, ICLR, IQV and 36 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.